Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Glucagon - Xeris Pharmaceuticals

Next Previous
X
Search
Drug Profile

Glucagon - Xeris Pharmaceuticals

Alternative Names: G-Pen; G-Pen Jr; G-Pen Mini; Glucagon infusion - Xeris; Glucagon RTU; Gvoke HypoPen; Gvoke PFS; Gvoke RTU Micro™; Gvoke® Kit; Injectable stable glucagon - Xeris; Ogluo; Ready-to-use glucagon; Xeris glucagon; XeriSol G-Pump; XP-9164

Latest Information Update: 09 May 2024

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator XERIS Pharmaceuticals
  • Developer Tetris Pharma; Xeris Pharmaceuticals
  • Class Antihypoglycaemics; Pancreatic hormones
  • Mechanism of Action Glucagon receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Hypoglycaemia
  • New Molecular Entity No
  • Available For Licensing Yes - Hypoglycaemia

Highest Development Phases

  • Marketed Hypoglycaemia
  • No development reported Gastrointestinal disorders

Most Recent Events

  • 06 May 2024 Glucagon licensed to Beta Bionics for bi-hormonal pump
  • 28 Jan 2024 No recent reports of development identified for phase-I development in Gastrointestinal-disorders in USA (Parenteral)
  • 20 Jul 2023 Xeris Pharmaceuticals plans to launch glucagon prefilled autoinjector pen (Ogluo®) for Hypoglycaemia in other key territories by second half of 2023

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top